By AACR Associate Member Council members, 2025-2026 Attending the AACR Annual Meeting is a defining moment for early‑career researchers...
Guest Post by Charles L. Sawyers, MD AACR Project GENIE Steering Committee Chairperson
Levi Garraway, MD, PhD, co-chair of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston Nov....
Guest Post by Varsha Gandhi, PhD The University of Texas MD Anderson Cancer Center
Carlos L. Arteaga, MD, past-president of the AACR, has been selected to receive the 2015 Prize for Scientific Excellence...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved a first-of-its kind immunotherapeutic, talimogene laherparepvec or T-Vec...
After being diagnosed with stage 4 stomach cancer, Debbie Zelman, Esq., started Debbie’s Dream Foundation: Curing Stomach Cancer (DDF)...
Eddy Shih-Hsin Yang, MD, PhD, associate professor and Regional Oncology Active Research (ROAR) Southeast Cancer Foundation Endowed Chair at...
Guest post by Michele R. McCorkle, RN, MSN Executive Director, Oncology Nursing Society
A half marathon is a challenging goal for anyone. Several members of the American Association for Cancer Research (AACR)...
Yesterday, Onivyde, which is a nanotherapeutic form of the conventional chemotherapeutic irinotecan, was approved by the U.S. Food and...